Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Can J Microbiol ; 66(2): 161-168, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31743042

RESUMEN

Nisin is a class I polycyclic bacteriocin produced by the bacterium Lactococcus lactis, which is used extensively as a food additive to inhibit the growth of foodborne Gram-positive bacteria. Nisin also inhibits growth of Gram-negative bacteria when combined with membrane-disrupting chelators such as citric acid. To gain insight into nisin's mode of action, we analyzed chemical-genetic interactions and identified nisin-sensitive Escherichia coli strains in the Keio library of knockout mutants. The most sensitive mutants fell into two main groups. The first group accords with the previously proposed mode of action based on studies with Gram-positive bacteria, whereby nisin interacts with factors involved in cell wall, membrane, envelope biogenesis. We identified an additional, novel mode of action for nisin based on the second group of sensitive mutants that involves cell cycle and DNA replication, recombination, and repair. Further analyses supported these two distinct modes of action.


Asunto(s)
Antibacterianos/farmacología , Conservantes de Alimentos/farmacología , Lactococcus lactis/química , Nisina/farmacología , Bacterias/metabolismo , Pared Celular/metabolismo , Reparación del ADN/efectos de los fármacos , Reparación del ADN/genética , Replicación del ADN/efectos de los fármacos , Replicación del ADN/genética , Escherichia coli/efectos de los fármacos , Técnicas de Inactivación de Genes , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos
2.
PLoS One ; 13(3): e0193111, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29554091

RESUMEN

Engineered nanomaterials (ENMs) are increasingly incorporated into a variety of commercial applications and consumer products; however, ENMs may possess cytotoxic properties due to their small size. This study assessed the effects of two commonly used ENMs, zinc oxide nanoparticles (ZnONPs) and silver nanoparticles (AgNPs), in the model eukaryote Saccharomyces cerevisiae. A collection of ≈4600 S. cerevisiae deletion mutant strains was used to deduce the genes, whose absence makes S. cerevisiae more prone to the cytotoxic effects of ZnONPs or AgNPs. We demonstrate that S. cerevisiae strains that lack genes involved in transmembrane and membrane transport, cellular ion homeostasis, and cell wall organization or biogenesis exhibited the highest sensitivity to ZnONPs. In contrast, strains that lack genes involved in transcription and RNA processing, cellular respiration, and endocytosis and vesicular transport exhibited the highest sensitivity to AgNPs. Secondary assays confirmed that ZnONPs affected cell wall function and integrity, whereas AgNPs exposure decreased transcription, reduced endocytosis, and led to a dysfunctional electron transport system. This study supports the use of S. cerevisiae Gene Deletion Array as an effective high-throughput technique to determine cellular targets of ENM toxicity.


Asunto(s)
Antifúngicos/farmacología , Citotoxinas/farmacología , Nanopartículas del Metal , Saccharomyces cerevisiae , Plata/farmacología , Óxido de Zinc/farmacología , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Especificidad de la Especie
3.
Mol Biosyst ; 10(4): 916-24, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24535059

RESUMEN

Protein biosynthesis is an orderly process that requires a balance between rate and accuracy. To produce a functional product, the fidelity of this process has to be maintained from start to finish. In order to systematically identify genes that affect stop codon bypass, three expression plasmids, pUKC817, pUKC818 and pUKC819, were integrated into the yeast non-essential loss-of-function gene array (5000 strains). These plasmids contain three different premature stop codons (UAA, UGA and UAG, respectively) within the LacZ expression cassette. A fourth plasmid, pUKC815 that carries the native LacZ gene was used as a control. Transformed strains were subjected to large-scale ß-galactosidase lift assay analysis to evaluate production of ß-galactosidase for each gene deletion strain. In this way 84 potential candidate genes that affect stop codon bypass were identified. Three candidate genes, OLA1, BSC2, and YNL040W, were further investigated, and were found to be important for cytoplasmic protein biosynthesis.


Asunto(s)
Adenosina Trifosfatasas/genética , Proteínas de Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/genética , Miembro 2 de la Familia de Transportadores de Soluto 12/genética , beta-Galactosidasa/genética , Adenosina Trifosfatasas/biosíntesis , Codón sin Sentido/genética , Eliminación de Gen , Operón Lac/genética , Plásmidos/genética , Biosíntesis de Proteínas/genética , Proteínas de Saccharomyces cerevisiae/biosíntesis , Miembro 2 de la Familia de Transportadores de Soluto 12/biosíntesis , beta-Galactosidasa/biosíntesis
4.
Int J Food Microbiol ; 164(1): 108-12, 2013 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-23624539

RESUMEN

The antimicrobial activity of chitosan has been acknowledged for more than 30 years and yet its mode-of-action remains ambiguous. We analyzed chemical-genetic interactions of low-molecular weight chitosan using a collection of ≈ 4600 S. cerevisiae deletion mutants and found that 31% of the 107 mutants most sensitive to chitosan had deletions of genes related primarily to functions involving protein synthesis. Disruption of protein synthesis by chitosan was substantiated by an in vivo ß-galactosidase expression assay suggesting that this is a primary mode of antifungal action. Analysis of the yeast gene deletion array and secondary assays also indicate that chitosan has a minor membrane disruption effect - a leading model of chitosan antimicrobial activity.


Asunto(s)
Antifúngicos/farmacología , Quitosano/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Saccharomyces cerevisiae/efectos de los fármacos , Antifúngicos/metabolismo , Membrana Celular/efectos de los fármacos , Quitosano/metabolismo , Activación Enzimática/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/biosíntesis , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Eliminación de Secuencia , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...